The role of phospholipases in lipid modification and atherosclerosis

By Ghesquiere Stijn   Hofker Marten   Winther Menno  

Cardiovascular Toxicology, Vol. 5, Iss. 2, 2005-06 ,pp. : 161-182

Humana Press, Inc

Access to resources Recommend Favorite

Advanced Glycation Endproducts and Their Receptor: Do They Play a Role in Diabetic Cardiomyopathy?

By Arai M.  

Journal of Molecular and Cellular Cardiology, Vol. 34, Iss. 10, 2002-10 ,pp. : 1305-1308

Academic Press

Access to resources Recommend Favorite

Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH

By Kimura Yuki   Hyogo Hideyuki   Yamagishi Sho-ichi   Takeuchi Masayoshi   Ishitobi Tomokazu   Nabeshima Yoshitaka   Arihiro Koji   Chayama Kazuaki  

Journal of Gastroenterology, Vol. 45, Iss. 7, 2010-07 ,pp. : 750-757

Springer Publishing Company

Access to resources Recommend Favorite

Lipoprotein modification and atherosclerosis in aging - a linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease

By Reaven P.D.   Napoli C.   Merat S.   Witztumc J.L.  

Experimental Gerontology, Vol. 34, Iss. 4, 1999-08 ,pp. : 527-537

Elsevier

Access to resources Recommend Favorite

Lipoprotein Lipase and Atherosclerosis

By  

Current Vascular Pharmacology, Vol. 1, Iss. 1, 2003-01 ,pp. : 11-17

Bentham Science Publishers

Access to resources Recommend Favorite